Elanco Animal Health (NYSE:ELAN) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.13, beating the consensus estimate of $0.11 by $0.02 per share. Revenue came in at $1.1B, beating the estimate of $1.1B.
Elanco Animal Health's stock moved following the earnings release. The stock currently trades at $27.12 with a market capitalization of $10.6B.


